The frequency of pulmonary hypertension in chronic obstructive pulmonary disease of geriatric patients: a narrative literature review

被引:1
|
作者
Luca, Ecaterina [1 ]
Bodrug, Nicolae [1 ]
机构
[1] State Univ Med & Pharm Nicolae Testemitanu, Dept Internal Med Discipline Geriatr & Occupat Med, Kishinev, Moldova
来源
EGYPTIAN JOURNAL OF INTERNAL MEDICINE | 2022年 / 34卷 / 01期
关键词
Pulmonary hypertension; Chronic obstructive pulmonary disease; Geriatric patients; Acute exacerbation; Echocardiography; ECHOCARDIOGRAPHY; PREVALENCE; DIAGNOSIS;
D O I
10.1186/s43162-022-00135-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension (PH) is a serious complication with complex pathogenesis in the natural history of chronic obstructive pulmonary disease COPD, with a progressively increasing frequency with a meanwhile decreasing in functional capacity. Purpose: Assessment of the incidence, pathogenesis, peculiarities, and complications of PH in COPD in geriatric population worldwide. Methods: We performed an analysis of randomized, retrospective, and prospective clinical, case-control and observational studies, published at the international level, according to the subject studied and target population. Four hundred ninety-seven full articles were identified after the search through engine Google Search and databases PubMed, Hinari, SpringerLink, and Scopus (Elsevier) according to the keywords and subsequent filters. Results: Depending on various factors, like the population examined, the definition used for mPAP (mPAP> 20 mm Hg or >= 25 mm Hg), the severity of the lung disease, and the method of measuring PAP, a varied incidence of COPD patients with PH complication was discovered, namely 10-91%. PH prevalence increases with the COPD severity. The presence of PH is associated with acute exacerbations of COPD, reduced survival, and increasing expenses for healthcare programs. Mild to moderate levels of PH (mPAP 25-34 mm Hg) are relatively common in COPD and usually are associated with severe airflow obstruction or parenchymal destruction. Only a minority of patients (1-5%) have severe PH (mPAP >= 35 mm Hg). Conclusions: Diagnosis of PH in COPD is difficult, especially in a mild form, and requires a clinical approach associated with a comprehensive set of investigations for confirming the etiology, evaluation of the functional and hemodynamical impairment severity, and important factors in the appropriate treatment election.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] The frequency of pulmonary hypertension in chronic obstructive pulmonary disease of geriatric patients: a narrative literature review
    Ecaterina Luca
    Nicolae Bodrug
    The Egyptian Journal of Internal Medicine, 2022, 34
  • [2] Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review
    Balbirsingh, Vishanna
    Mohammed, Andrea S.
    Turner, Alice M.
    Newnham, Michael
    THORAX, 2022, 77 (09) : 939 - 945
  • [3] Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke
    Sertogullarindan, Bunyamin
    Gumrukcuoglu, Hasan Ali
    Sezgi, Cengizhan
    Akil, Mehmet Ata
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: A pathophysiologic review
    Wrobel, Jeremy P.
    Thompson, Bruce R.
    Williams, Trevor J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (06): : 557 - 564
  • [5] Pulmonary hypertension in chronic obstructive pulmonary disease
    Gredic, Marija
    Blanco, Isabel
    Kovacs, Gabor
    Helyes, Zsuzsanna
    Ferdinandy, Peter
    Olschewski, Horst
    Barbera, Joan Albert
    Weissmann, Norbert
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (01) : 132 - 151
  • [6] Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
    Yakovleva, Olga
    Masloiid, Tatiana
    Klekot, Alexandra
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [7] Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
    Kiral, Nesrin
    EURASIAN JOURNAL OF PULMONOLOGY, 2010, 12 (03) : 101 - 111
  • [8] Pulmonary hypertension in chronic obstructive pulmonary disease
    Barberà, JA
    Peinado, VI
    Santos, S
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (05) : 892 - 905
  • [9] Effects of Trimetazidine on patients with chronic obstructive pulmonary disease and pulmonary hypertension
    Oh, S. J.
    Yoon, S. J.
    Jeon, D. W.
    Yang, J. Y.
    Dk, C. H. O.
    EUROPEAN HEART JOURNAL, 2015, 36 : 963 - 963
  • [10] Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
    Chen, Chung-Yu
    Wu, Wen-Ting
    Wang, Ya-Ling
    Liao, Kuang-Ming
    FRONTIERS IN PHARMACOLOGY, 2021, 11